Rykin_Capital

Shorting Lyell Immunopharma. LYEL

做空
Rykin_Capital 已更新   
NASDAQ:LYEL   Lyell Immunopharma, Inc.
Believing B/C pivot just happened and we are moving down. Since we recover to ~ 0.618 of A we may reach new lows in this run downwards.

We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
交易结束:到达目标:
First two by 7th OCT

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。